← Back to Patent Explorer
US4031239A Expired / Lapsed US ⏱️ 0.0 years remaining

Cyclopropanecarboxylates for systemic control of ectoparasites

Assignee: Wyeth Holdings LLC
•
Filing: 1975-12-22
•
Granted: 1977-06-21
•
Expires: 1995-12-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention is a method for controlling ectoparasites using cyclopropanecarboxylate compounds having systemic activity in warm-blooded animals.

Inventors

  • 👤 Michael Stanley Schrider

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 01:34
CPC Classifications
A; A23; A23K; A23K20/00; A23K20/10; A23K20/111

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 47 words
A method for the systemic control of ectoparasites which attack warm-blooded animals comprising orally or parenterally administering to the animals a systemically effective amount against the parasites of a cyclopropanecarboxylic acid of the formula: ##STR9## wherein R is 2,2-dichlorovinyl- or 2-methyl-propenyl- and R' is hydrogen or cyano.
Claim 2
Independent Claim 47 words
A method for the systemic control of ectoparasites which attack warm-blooded animals comprising orally or parenterally administering to the animals a systemically effective amount against the parasites of a cyclopropanecarboxylic acid of the formula: ##STR9## wherein R is 2,2-dichlorovinyl- or 2-methyl-propenyl- and R' is hydrogen or cyano.
Claim 3
Dependent Claim 38 words
A method according to claim 1 for the control of ixodid ticks, wherein the compound cyclopropanecarboxylic acid, 3-(2,2-dichlorovinyl)-2,2-dimethyl-m-phenoxybenzyl ester, cis- trans isomer is administered orally in amounts of 0.01 mg to 600 mg per kilogram animal body weight.
Claim 4
Dependent Claim 38 words
A method according to claim 1 for the control of ixodid ticks wherein the compound cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-propenyl)-m-phenoxybenzyl ester cis and trans isomersis administered orally in amounts of 0.01 mg to 600 mg per kilogram animal body weight.
Claim 5
Dependent Claim 25 words
A method according to claim 2, wherein the compound is administered orally in amounts of 100 mg to 400 mg per kilogram animal body weight.
Claim 6
Dependent Claim 25 words
A method according to claim 3, wherein the compound is administered orally in amounts of 100 mg to 400 mg per kilogram animal body weight.
Claim 7
Dependent Claim 29 words
A method according to claim 1 for the control of ixodid ticks, wherein the compound is introduced into the animal's circulatory system by a subcutaneous, intramuscular or intraperitoneal injection.
Claim 8
Dependent Claim 35 words
A method according to claim 6, wherein the compound cyclopropanecarboxylic acid, 3-(2,2-dichlorovinyl)-2,2-dimethyl-m-phenoxybenzyl ester cis-trans isomers is introduced into the animals circulatory system in amounts of 0.01 mg to 600 mg per kilogram animal body weight.
Claim 9
Dependent Claim 35 words
A method according to claim 6, wherein the compound cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methylpropenyl)-m-phenoxybenzyl ester, cis-trans isomers is introduced into the animals circulatory system in amounts of 0.01 mg to 600 mg per kilogram animal body weight.
Claim 10
Dependent Claim 26 words
A method according to claim 7, wherein said compound is introduced into the animals circulatory system in amounts of 100 mg per kilogram animal body weight.
Claim 11
Dependent Claim 29 words
A method according to claim 8, wherein said compound is introduced into the animal's circulatory system in amounts of 100 mg to 400 mg per kilogram animal body weight.
Claim 12
Dependent Claim 33 words
A method according to claim 1 for the control of ixodid ticks wherein the compound is incorporated in a nutritionally balanced animal feed in amounts of 0.01% to 2.5% by weight of feed.
Claim 13
Dependent Claim 27 words
A method according to claim 11, wherein the compound cyclopropanecarboxylic acid, 3-(2,2-dichlorovinyl)-2,2-dimethyl-m-phenoxybenzyl ester, cis-trans isomers is incorporated in amounts of 0.01% to 1.0% by weight of feed.
Claim 14
Dependent Claim 27 words
A method according to claim 11, wherein the compound cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-propenyl)-m-phenoxybenzyl ester, cis-trans isomere is incorporated in amounts of 0.01% to 1.0% by weight of feed.
Claim 15
Dependent Claim 39 words
A method according to claim 1 for the control of ixodid ticks wherein the compound cyclopropanecarboxylic acid, 3-(2-2-dichlorovinyl)-2,2-dimethyl-α-cyano-m-phenoxybenzyl ester, cis and trans isomers is administered orally in amounts of 0.01 mg to 600 mg per kilogram animal body weight.
Claim 16
Dependent Claim 40 words
A method according to claim 1 for the control of ixodid ticks wherein the compound cyclopropane carboxylic acid, 2,2-dimethyl-3-(2-methyl-propenyl)-α-cyano-m-phenoxybenzyl ester cis and trans isomers is administered orally in amounts of 0.01 mg to 600 mg per kilogram animal body weight.

References Cited (Backward Citations)

US3666789A Cited
US3835176A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-06-20 1980-12-20 1981-06-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-06-20 1984-12-20 1985-06-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-06-20 1988-12-20 1989-06-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag